¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷) : 2019-05-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷) : 2019-05-17
±³À°ÀÏÀÚ : 2019-05-17
±³À°Àå¼Ò : ÇÏÀÌ¿ø±×·£µåÈ£ÅÚ ÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ  
±³À°ÁÖÁ¦ : Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ  
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070  
À̸ÞÀÏ : office@intervention.or.kr      
±³À°Á¾·ù : ¿µ»óÀÇÇаúÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥,      
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : °­¿øµµ
±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í »çÀüµî·Ï:Á¤È¸¿ø 50000¿ø, Àü¹®ÀÇ 100000¿ø, °øº¸.Àü°øÀÇ 30000¿ø, ÁØȸ¿ø 50000¿ø/ÇöÀåµî·Ï: Á¤È¸¿ø 70000¿ø, Àü¹®ÀÇ 120000¿ø, °øº¸.Àü°øÀÇ 50000¿ø, ÁØȸ¿ø 70000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:00~13:10 Iatrogenic Arterioportal Fistula Caused by Radiofrequency Ablation of Hepatocellular Carcinoma: Clinical Courses and Treatment Outcomes  ÃÖÁø¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:10~13:20 Radioembolization of hepatocellular carcinoma in a large single center cohort: response and survival evaluation  ±è°æ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:20~13:30 Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by conventional transcatheter arterial chemoembolization: threshold value of intratumoral Lipiodol accumulation predicting tumor necrosis  ¹ÚÂù(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:30~13:40 Spectral CT-based iodized oil quantification to develop a tumor response prediction model for chemoembolization of hepatocellular carcinoma  ÃÖ¿ø¼®(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:40~13:50 HepaSphere (30–60 ¥ìm) Transarterial Chemoembolization vs. Conventional Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score Matched Analysis of Early Clinical Outcomes  ±èÁø¿µ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:50~14:00 AORTOCELIAC ANGLE IN PERCUTANEOUS IMPLANTATION OF PORT-CATHETER SYSTEM FOR HEPATIC ARTERIAL INFUSION CHEMOTHERAPY: COMPARISON OF SUBCLAVIAN VS FEMORAL APPROACH  ±è¼öÈ£(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:00~14:10 BTK angioplasty using subintimal rendezvous via dorsalis pedis artery  °­Ã¤ÈÆ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:10~14:20 RFA of oligometastasis of lymph nodes and peritoneum in the abdominal and pelvic cavity from non-hepatocellular carcinoma  Á¤µ¿Áø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:20~14:30 Retrograde Thoracic Duct Embolization  À±Á¦È«(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:30~14:40 Interventional Treatment of uncontrolled urine leakage: 2 cases  ¼­Å¼®(°í´ëÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:40~14:50 Transrenal hemodialysis catheter insertion  ½ÅÁöÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:50~15:00 Endovascular Treatment of Traumatic Suprahepatic IVC Rupture  ±èÇü¿í(Àü³²ÀÇ´ë) 
Åä·Ð 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:00~15:10 Discussion  Á¶¿µÁØ, ÀÓ³²¿­, Çã¼¼¹ü(ÀÎÁ¦ÀÇ´ë, Àü³²ÀÇ´ë, ¼­¿ïÀÇ´ë) 
È޽Ġ05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:10~15:30 Coffee break  () 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:30~15:45 Pediatric Interventional Radiology: General Considerations  Lisa Kang() 
Åä·Ð 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:45~16:00 Discussion  °í±â¿µ, ±è¹Î¿í, Àü¿õ¹è(¿ï»êÀÇ´ë, ÀÌÈ­ÀÇ´ë, ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:00~16:15 Hepatobiliary surgery  Àüâȣ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:15~16:30 Esophageal and lung surgery  Çöµ¿È£(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:30~16:45 Gastrectomy  Çѱââ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:45~17:00 Urologic surgery  ÀÌ¿õÈñ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:00~17:10 What¡¯s new-Cook  ÀÌ¿ì¶÷(Cook) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:10~17:20 What¡¯s new-Boston Scientific  ½ÉÀçÇö(Boston Scientific) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:20~17:30 What¡¯s new-Phillips  À̼ºÈñ(Phillips) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:30~17:40 What¡¯s new-¢ß¿¡½º¿ÍÀ̸޵ðÄɾÀ̹μ®(¢ß¿¡½º¿ÍÀ̸޵ðÄɾî) 
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:40~17:50 What¡¯s new-Teleflex Korea  ±è½ÅÈ£(Teleflex Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷) : 2019-05-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÇØ¿î´ë¹éº´¿ø ´ëÇÑÁ¶Çöº´ÇÐȸ What's New in Schizophrenia: Research and Practice : 2019-05-17
´ÙÀ½±Û ¼­¿ï¾Æ»êº´¿ø ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 5¿ù ¿ù·ÊÁý´ãȸ : 2019-05-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20222 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Æó°æÈ£¸£¸óÀÇ »îÀÇ Áú, È£¸£¸óÀÇ ¿ªÇÒ) : 2024-04-02 0 58 2024-04-01
20221 °æ±â ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ ¿ëÀÎÁö¿ª Çмú´ëȸ : 2024-04-28 0 147 2024-03-26
20220 ¼­¿ï (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28 0 19,610 2024-03-26
20219 ¼­¿ï 2024³â ´ëÇÑÇ׳ëÈ­ÇÐȸ Á¦23ȸ Ãá°èÇмú´ëȸ : 2024-04-28 0 303 2024-03-26
20218 Àü³² 2024³â Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãá°èÇмú´ëȸ : 2024-04-27 0 118 2024-03-26
20217 °­¿ø 2024³â ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °­¿øÁöȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-27 0 146 2024-03-26
20216 °æ±â 2024³â ´ëÇѽºÆ÷Ã÷°úÇС¤¿îµ¿ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-27 0 136 2024-03-26
20215 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ (¿Â¶óÀÎ) The 18th Basic Critical Care Review Course (BCCRC) : 2024-04-27 0 143 2024-03-26
20214 °æ±â ´ëÇѵΰæºÎ¿Ü°úÇÐȸ 2024 Ãá°è µÎ°æºÎ ÇÕµ¿¿¬¼öȸ : 2024-04-27 0 176 2024-03-26
20213 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ The 44th KSCCM Annual Congress ¡¤ Acute and Critical Care Conference 2024(2ÀÏÂ÷) : 2024-04-26 0 118 2024-03-26
20212 °æ±â °í·Á´ëÇб³¾È»êº´¿ø ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¸¸¼ººñºÎºñµ¿¿°) : 2024-04-26 0 110 2024-03-26
20211 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ(Biomechanics in Glaucoma) : 2024-04-26 0 83 2024-03-26
20210 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 509ȸ ÇмúÁý´ãȸ : 2024-04-25 0 86 2024-03-26
20209 ¼­¿ï ´ëÇÑÁßȯÀÚÀÇÇÐȸ The 44th KSCCM Annual Congress ¡¤ Acute and Critical Care Conference 2024(1ÀÏÂ÷) : 2024-04-25 0 132 2024-03-26
20208 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ÀÇ ¿¹¹æÁ¢Á¾ Àü·«°ú ³ëÇÏ¿ì: HPV ¹é½ÅÀ» Áß½ÉÀ¸·Î : 2024-04-25 0 123 2024-03-26
61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷